A novel biomarker and hepato-protector for acetaminophen-induced liver injury

As the most common cause of acute liver failure in Western countries, acetaminophen-induced liver injury (AILI) is always a significant public health concern.1,2 Acetaminophen, also known as paracetamol, is one of the most commonly used medications for its analgesic and antipyretic effects.1,2 It is available over the counter both as a single formulation and in combination with other medications. While acetaminophen is a safe and effective drug at recommended doses, it has the potential of acute liver injury when overdose.

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2eXNC4H
via IFTTT